全球COVID-19治療藥物市場研究報告 - 行業分析、規模、佔有率、成長、趨勢及2023年至2030年預測

預計到2030年，全球COVID-19治療藥物市場需求將從2022年的339.2億美元成長到749.6億美元，2023-2030年的複合年成長率為10.42%。

COVID-19療法是指用於治療由SARS-CoV-2病毒引起的呼吸道疾病COVID-19的藥物和療法。 COVID-19療法包括抗病毒藥物、免疫調節藥物和單克隆抗體等。 COVID-19療法的目標是減輕症狀、預防併發症和改善COVID-19患者的總體預後。

市場動態：

COVID-19大流行導致對COVID-19治療藥物的高需求，原因是病例數量不斷增加，需要有效的治療方案。世界各國政府正在提供資金和支持，以加速COVID-19療法的開發和供應。這導致了研發投資的增加，以及監管部門對加快批准潛在療法的支持。新變種的出現導致對能有效治療這些新病毒株的COVID-19療法的需求增加。隨著科學界對COVID-19的進一步了解，新的治療靶點正在被確定，從而開發出可能更有效治療該疾病的新型療法。包括製藥公司和研究機構在內的醫療機構之間的合作正在推動COVID-19療法的開發和供應。

研究報告涵蓋波特五力模型、市場吸引力分析和價值鏈分析。這些工具有助於在全球範圍內清晰地了解行業結構並評估競爭吸引力。此外，這些工具還對COVID-19療法全球市場的各個細分市場進行了全面評估。 COVID-19治療劑行業的成長和趨勢為本研究提供了整體方法。

市場細分：

COVID-19治療劑市場報告的這一部分提供了國家和地區層面細分市場的詳細數據，從而幫助戰略家確定各自產品或服務的目標人群以及即將到來的機會。

按藥物類別

• 皮質類固醇
• 抗病毒藥物
• 單克隆抗體
• 激酶抑製劑
• 其他（抗發炎藥物、康復血漿、其他）

按給藥途徑

• 口服
• 腸外

按銷售管道

• 醫院藥房
• 零售藥店
• 網上藥店

區域分析

本節涵蓋區域前景，重點介紹北美、歐洲、亞太、拉丁美洲以及中東和非洲地區COVID-19治療藥物市場的當前和未來需求。此外，報告還重點介紹了所有主要地區各個應用領域的需求、估計和預測。

• 全球COVID-19治療劑各地區市場佔有率（代表圖）
• 全球COVID-19治療藥物市場佔有率

研究報告還涵蓋了市場中主要企業的綜合概況以及全球競爭格局的深入分析。 COVID-19治療劑市場的主要參與者包括F.Hoffmann-La Roche Ltd、Gilead Sciences Inc、Eli Lilly and Company、Pfizer Inc、Merck & Co.Inc., GSK plc, Celltrion Healthcare Co.Ltd、Sorrento Therapeutics、AstraZeneca plc。本部分包括競爭格局的整體視圖，其中包括各種戰略發展，如關鍵併購、未來能力、合作夥伴關係、財務概況、合作、新產品開發、新產品上市和其他發展。

如果您有任何客製化要求，請聯繫我們。我們的研究團隊可以根據您的需求提供客製化報告。

目 錄

第一章：前言

• 報告描述
  • 報告目標
  • 目標受眾
  • 獨特銷售主張（USP）和產品
• 研究範圍
• 研究方法
  • 市場調研流程
  • 市場調研方法

第二章：執行摘要

• 市場亮點
• 全球市場概況

第3章：Covid-19療法- 行業分析

• 簡介- 市場動態
• 市場驅動因素
• 市場限制因素
• 市場機會
• 行業趨勢
• 波特五力分析
• 市場吸引力分析
  • 按藥物類別分類的市場吸引力分析
  • 按給藥途徑的市場吸引力分析
  • 按銷售管道的市場吸引力分析
  • 市場吸引力分析：按地區

第四章：價值鏈分析

• 價值鏈分析
• 原料分析
  • 原料清單
  • 原料製造商列表
  • 主要原料價格走勢
• 潛在買家名單
• 行銷管道
  • 直接行銷
  • 間接行銷
  • 行銷管道發展趨勢

第五章：covid-19爆發的影響分析

第六章：全球covid-19治療藥物市場分析：按藥物類別分類

• 按藥物類別概述
• 歷史和預測數據
• 按藥物類別分析
• 皮質類固醇
• 抗病毒藥物
• 單克隆抗體
• 激酶抑製劑
• 其他（抗發炎藥物、康復血漿、其他）

第七章：全球Covid-19治療藥物市場分析：按給藥途徑分類

• 給藥途徑概述
• 歷史和預測數據
• 按給藥途徑分析
• 口服
• 腸外

第八章：全球covid-19治療藥物市場銷售分析：按配銷通路分析

• 配銷通路概述
• 歷史和預測數據
• 按銷售管道分析
• 醫院藥房
• 零售藥店
• 網上藥店

第9章：全球Covid-19治療劑市場銷售分析：按地區分類

• 地區展望銷售分析
• 銷售分析
• 北美銷售分析
  • 概述，歷史和預測銷售分析
  • 北美地區銷售分析
  • 北美各國銷售分析
  • 美國銷售分析
  • 加拿大銷售分析
  • 墨西哥銷售分析
• 歐洲銷售分析
  • 概述、歷史和預測銷售分析
  • 歐洲銷售分析
  • 歐洲各國銷售分析
  • 英國銷售分析
  • 法國銷售分析
  • 德國銷售分析
  • 義大利銷售分析
  • 俄羅斯銷售分析
  • 歐洲其他地區銷售分析
• 亞太地區銷售分析
  • 概述、歷史和預測銷售分析
  • 亞太地區各細分市場銷售分析
  • 亞太地區各國銷售分析
  • 中國銷售分析
  • 印度銷售分析
  • 日本銷售分析
  • 韓國銷售分析
  • 澳大利亞銷售分析
  • 亞太其他地區銷售分析
• 拉丁美洲銷售分析
  • 概述、歷史和預測銷售分析
  • 拉丁美洲各細分市場銷售分析
  • 拉丁美洲各國銷售分析
  • 巴西銷售分析
  • 阿根廷銷售分析
  • 秘魯銷售分析
  • 智利銷售分析
  • 拉丁美洲其他地區銷售分析
• 中東和非洲銷售分析
  • 概述、歷史和預測銷售分析
  • 中東及非洲地區銷售分析
  • 中東和非洲國家銷售分析
  • 沙烏地阿拉伯銷售分析
  • 阿拉伯聯合大公國銷售分析
  • 以色列銷售分析
  • 南非銷售分析
  • 中東和非洲其他地區銷售分析

第10章: Covid-19治療劑公司的競爭格局

• Covid-19治療劑市場競爭格局
• 夥伴關係/合作/協議
• 合併與收購
• 新產品上市
• 其他發展

第十一章：公司概況

• 前10強企業佔有率分析
• 市場集中率
• F.Hoffmann-La Roche Ltd
  • 公司概況
  • 公司收入
  • 產品
  • 近期發展
• Gilead Sciences Inc.
  • 公司概況
  • 公司收入
  • 產品
  • 近期發展
• Eli Lilly and Company
  • 公司概況
  • 公司收入
  • 產品
  • 近期發展
• Pfizer Inc.
  • 公司概況
  • 公司收入
  • 產品
  • 近期發展
• Merck & Co. Inc.
  • 公司概況
  • 公司收入
  • 產品
  • 近期發展
• GSK plc
  • 公司概況
  • 公司收入
  • 產品
  • 近期發展
• Celltrion Healthcare Co. Ltd
  • 公司概況
  • 公司收入
  • 產品
  • 近期發展
• Sorrento Therapeutics
  • 公司概況
  • 公司收入
  • 產品
  • 近期發展
• AstraZeneca plc.
  • 公司概況
  • 公司收入
  • 產品
  • 近期發展

注-在公司概況中，財務細節和近期發展視情況而定，如果是私營公司則可能不包括在內。

The global demand for COVID-19 Therapeutics Market is presumed to reach the market size of nearly USD 74.96 BN by 2030 from USD 33.92 BN in 2022 with a CAGR of 10.42% under the study period 2023 - 2030.

COVID-19 therapeutics refer to the drugs and therapies used for the treatment of COVID-19, the respiratory illness caused by the SARS-CoV-2 virus. COVID-19 therapeutics include antiviral drugs, immunomodulatory drugs, and monoclonal antibodies, among others. The goal of COVID-19 therapeutics is to reduce the severity of symptoms, prevent complications, and improve the overall outcomes of patients with COVID-19.

Market Dynamics:

The COVID-19 pandemic has resulted in high demand for COVID-19 therapeutics due to the increasing number of cases and the need for effective treatment options. Governments worldwide are providing funding and support to accelerate the development and availability of COVID-19 therapeutics. This has led to increased investment in research and development, as well as regulatory support for the expedited approval of potential therapies. The emergence of new variants has led to an increased need for COVID-19 therapeutics that can effectively treat these new strains of the virus. New therapeutic targets are being identified as the scientific community learns more about COVID-19, leading to the development of novel therapies that may be more effective in treating the disease. Collaboration among healthcare organizations, including pharmaceutical companies and research institutions, is driving the development and availability of COVID-19 therapeutics.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of COVID-19 therapeutics. The growth and trends of COVID-19 therapeutics industry provide a holistic approach to this study.

Market Segmentation:

This section of the COVID-19 therapeutics market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Drug Class

• Corticosteroids
• Anti-Viral
• Monoclonal Antibodies
• Kinase Inhibitors
• Others (Anti-Inflammatory Drugs, Convalescent Plasma, Others)

By Route Of Administration

• Oral
• Parenteral

By Distribution Channel

• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies

Regional Analysis

This section covers the regional outlook, which accentuates current and future demand for the COVID-19 Therapeutics market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

• Global COVID-19 Therapeutics Market Share by Region (Representative Graph)
• Global COVID-19 Therapeutics Market Share

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the COVID-19 therapeutics market include F.Hoffmann-La Roche Ltd, Gilead Sciences Inc., Eli Lilly and Company, Pfizer Inc., Merck & Co. Inc., GSK plc, Celltrion Healthcare Co. Ltd, Sorrento Therapeutics, AstraZeneca plc. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

TABLE OF CONTENTS

1 . PREFACE

• 1.1. Report Description
  • 1.1.1. Objective
  • 1.1.2. Target Audience
  • 1.1.3. Unique Selling Proposition (USP) & offerings
• 1.2. Research Scope
• 1.3. Research Methodology
  • 1.3.1. Market Research Process
  • 1.3.2. Market Research Methodology

2 . EXECUTIVE SUMMARY

• 2.1. Highlights of Market
• 2.2. Global Market Snapshot

3 . COVID-19 THERAPEUTICS - INDUSTRY ANALYSIS

• 3.1. Introduction - Market Dynamics
• 3.2. Market Drivers
• 3.3. Market Restraints
• 3.4. Opportunities
• 3.5. Industry Trends
• 3.6. Porter's Five Force Analysis
• 3.7. Market Attractiveness Analysis
  • 3.7.1 Market Attractiveness Analysis By Drug Class
  • 3.7.2 Market Attractiveness Analysis By Route Of Administration
  • 3.7.3 Market Attractiveness Analysis By Distribution Channel
  • 3.7.4 Market Attractiveness Analysis By Region

4 . VALUE CHAIN ANALYSIS

• 4.1. Value Chain Analysis
• 4.2. Raw Material Analysis
  • 4.2.1. List of Raw Materials
  • 4.2.2. Raw Material Manufactures List
  • 4.2.3. Price Trend of Key Raw Materials
• 4.3. List of Potential Buyers
• 4.4. Marketing Channel
  • 4.4.1. Direct Marketing
  • 4.4.2. Indirect Marketing
  • 4.4.3. Marketing Channel Development Trend

5 . IMPACT ANALYSIS OF COVID-19 OUTBREAK

6 . GLOBAL COVID-19 THERAPEUTICS MARKET ANALYSIS BY DRUG CLASS

• 6.1 Overview by Drug Class
• 6.2 Historical and Forecast Data
• 6.3 Analysis by Drug Class
• 6.4 Corticosteroids Historic and Forecast Sales by Regions
• 6.5 Anti-viral Historic and Forecast Sales by Regions
• 6.6 Monoclonal Antibodies Historic and Forecast Sales by Regions
• 6.7 Kinase Inhibitors Historic and Forecast Sales by Regions
• 6.8 Others (Anti-inflammatory Drugs, Convalescent Plasma, Others) Historic and Forecast Sales by Regions

7 . GLOBAL COVID-19 THERAPEUTICS MARKET ANALYSIS BY ROUTE OF ADMINISTRATION

• 7.1 Overview by Route Of Administration
• 7.2 Historical and Forecast Data
• 7.3 Analysis by Route Of Administration
• 7.4 Oral Historic and Forecast Sales by Regions
• 7.5 Parenteral Historic and Forecast Sales by Regions

8 . GLOBAL COVID-19 THERAPEUTICS MARKET SALES ANALYSIS BY DISTRIBUTION CHANNEL

• 8.1 Overview by Distribution Channel
• 8.2 Historical and Forecast Data
• 8.3 Analysis by Distribution Channel
• 8.4 Hospital Pharmacies Historic and Forecast Sales by Regions
• 8.5 Retail Pharmacies Historic and Forecast Sales by Regions
• 8.6 Online Pharmacies Historic and Forecast Sales by Regions

9 . GLOBAL COVID-19 THERAPEUTICS MARKET SALES ANALYSIS BY GEOGRAPHY

• 9.1. Regional Outlook Sales Analysis
• 9.2. Introduction Sales Analysis
• 9.3. North America Sales Analysis
  • 9.3.1. Overview, Historic and Forecast Sales Analysis
  • 9.3.2. North America By Segment Sales Analysis
  • 9.3.3. North America By Country Sales Analysis
  • 9.3.4. United State Sales Analysis
  • 9.3.5. Canada Sales Analysis
  • 9.3.6. Mexico Sales Analysis
• 9.4. Europe Sales Analysis
  • 9.4.1. Overview, Historic and Forecast Sales Analysis
  • 9.4.2. Europe by Segment Sales Analysis
  • 9.4.3. Europe by Country Sales Analysis
  • 9.4.4. United Kingdom Sales Analysis
  • 9.4.5. France Sales Analysis
  • 9.4.6. Germany Sales Analysis
  • 9.4.7. Italy Sales Analysis
  • 9.4.8. Russia Sales Analysis
  • 9.4.9. Rest Of Europe Sales Analysis
• 9.5. Asia Pacific Sales Analysis
  • 9.5.1. Overview, Historic and Forecast Sales Analysis
  • 9.5.2. Asia Pacific by Segment Sales Analysis
  • 9.5.3. Asia Pacific by Country Sales Analysis
  • 9.5.4. China Sales Analysis
  • 9.5.5. India Sales Analysis
  • 9.5.6. Japan Sales Analysis
  • 9.5.7. South Korea Sales Analysis
  • 9.5.8. Australia Sales Analysis
  • 9.5.9. Rest Of Asia Pacific Sales Analysis
• 9.6. Latin America Sales Analysis
  • 9.6.1. Overview, Historic and Forecast Sales Analysis
  • 9.6.2. Latin America by Segment Sales Analysis
  • 9.6.3. Latin America by Country Sales Analysis
  • 9.6.4. Brazil Sales Analysis
  • 9.6.5. Argentina Sales Analysis
  • 9.6.6. Peru Sales Analysis
  • 9.6.7. Chile Sales Analysis
  • 9.6.8. Rest of Latin America Sales Analysis
• 9.7. Middle East & Africa Sales Analysis
  • 9.7.1. Overview, Historic and Forecast Sales Analysis
  • 9.7.2. Middle East & Africa by Segment Sales Analysis
  • 9.7.3. Middle East & Africa by Country Sales Analysis
  • 9.7.4. Saudi Arabia Sales Analysis
  • 9.7.5. UAE Sales Analysis
  • 9.7.6. Israel Sales Analysis
  • 9.7.7. South Africa Sales Analysis
  • 9.7.8. Rest Of Middle East And Africa Sales Analysis

10 . COMPETITIVE LANDSCAPE OF THE COVID-19 THERAPEUTICS COMPANIES

• 10.1. Covid-19 Therapeutics Market Competition
• 10.2. Partnership/Collaboration/Agreement
• 10.3. Merger And Acquisitions
• 10.4. New Product Launch
• 10.5. Other Developments

11 . COMPANY PROFILES OF COVID-19 THERAPEUTICS INDUSTRY

• 11.1. Top 10 Company Share Analysis
• 11.2. Market Concentration Rate
• 11.3. F.Hoffmann-La Roche Ltd
  • 11.3.1. Company Overview
  • 11.3.2. Company Revenue
  • 11.3.3. Products
  • 11.3.4. Recent Developments
• 11.4. Gilead Sciences Inc.
  • 11.4.1. Company Overview
  • 11.4.2. Company Revenue
  • 11.4.3. Products
  • 11.4.4. Recent Developments
• 11.5. Eli Lilly and Company
  • 11.5.1. Company Overview
  • 11.5.2. Company Revenue
  • 11.5.3. Products
  • 11.5.4. Recent Developments
• 11.6. Pfizer Inc.
  • 11.6.1. Company Overview
  • 11.6.2. Company Revenue
  • 11.6.3. Products
  • 11.6.4. Recent Developments
• 11.7. Merck & Co. Inc.
  • 11.7.1. Company Overview
  • 11.7.2. Company Revenue
  • 11.7.3. Products
  • 11.7.4. Recent Developments
• 11.8. GSK plc
  • 11.8.1. Company Overview
  • 11.8.2. Company Revenue
  • 11.8.3. Products
  • 11.8.4. Recent Developments
• 11.9. Celltrion Healthcare Co. Ltd
  • 11.9.1. Company Overview
  • 11.9.2. Company Revenue
  • 11.9.3. Products
  • 11.9.4. Recent Developments
• 11.10. Sorrento Therapeutics
  • 11.10.1. Company Overview
  • 11.10.2. Company Revenue
  • 11.10.3. Products
  • 11.10.4. Recent Developments
• 11.11. AstraZeneca plc.
  • 11.11.1. Company Overview
  • 11.11.2. Company Revenue
  • 11.11.3. Products
  • 11.11.4. Recent Developments

Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies

LIST OF TABLES

• Market Snapshot
• Drivers : Impact Analysis
• Restraints : Impact Analysis
• List of Raw Material
• List of Raw Material Manufactures
• List of Potential Buyers
• Analysis by Drug Class (USD MN)
• Corticosteroids Market Sales by Geography (USD MN)
• Anti-viral Market Sales by Geography (USD MN)
• Monoclonal Antibodies Market Sales by Geography (USD MN)
• Kinase Inhibitors Market Sales by Geography (USD MN)
• Others (Anti-inflammatory Drugs, Convalescent Plasma, Others) Market Sales by Geography (USD MN)
• Analysis Market by Route Of Administration (USD MN)
• Oral Market Sales by Geography (USD MN)
• Parenteral Market Sales by Geography (USD MN)
• Analysis by Distribution Channel (USD MN)
• Hospital Pharmacies Market Sales by Geography (USD MN)
• Retail Pharmacies Market Sales by Geography (USD MN)
• Online Pharmacies Market Sales by Geography (USD MN)
• Global Covid-19 Therapeutics Market Sales by Geography (USD MN)
• North America Market Analysis (USD MN)
• United State Market Analysis (USD MN)
• Canada Market Analysis (USD MN)
• Mexico Market Analysis (USD MN)
• Europe Market Analysis (USD MN)
• Europe Market Estimate by Country (USD MN)
• United Kingdom Market Analysis (USD MN)
• France Market Analysis (USD MN)
• Germany Market Analysis (USD MN)
• Italy Market Analysis (USD MN)
• Russia Market Analysis (USD MN)
• Spain Market Analysis (USD MN)
• Rest of Europe Market Analysis (USD MN)
• Asia Pacific Market Analysis (USD MN)
• China Market Analysis (USD MN)
• Japan Market Analysis (USD MN)
• India Market Analysis (USD MN)
• South Korea Market Analysis (USD MN)
• Australia Market Analysis (USD MN)
• Rest of Asia Pacific Market Analysis (USD MN)
• Latin America Market Analysis (USD MN)
• Brazil Market Analysis (USD MN)
• Argentina Market Analysis (USD MN)
• Peru Market Analysis (USD MN)
• Chile Market Analysis (USD MN)
• Rest of Latin America Market Analysis (USD MN)
• Middle East & Africa Market Analysis (USD MN)
• Saudi Arabia Market Analysis (USD MN)
• UAE Market Analysis (USD MN)
• Israel Market Analysis (USD MN)
• South Africa Market Analysis (USD MN)
• Rest of Middle East and Africa Market Analysis (USD MN)
• Partnership/Collaboration/Agreement
• Mergers And Acquisition

LIST OF FIGURES

• Research Scope of Covid-19 Therapeutics Report
• Market Research Process
• Market Research Methodology
• Global Covid-19 Therapeutics Market Size, by Region (USD MN)
• Porters Five Forces Analysis
• Market Attractiveness Analysis by Drug Class
• Market Attractiveness Analysis by Route Of Administration
• Market Attractiveness Analysis by Distribution Channel
• Market Attractiveness Analysis by Region
• Value Chain Analysis
• Global Market Analysis by Drug Class (USD MN)
• Corticosteroids Market Sales by Geography (USD MN)
• Anti-viral Market Sales by Geography (USD MN)
• Monoclonal Antibodies Market Sales by Geography (USD MN)
• Kinase Inhibitors Market Sales by Geography (USD MN)
• Others (Anti-inflammatory Drugs, Convalescent Plasma, Others) Market Sales by Geography (USD MN)
• Global Market Analysis by Route Of Administration (USD MN)
• Oral Market Sales by Geography (USD MN)
• Parenteral Market Sales by Geography (USD MN)
• Global Market Analysis by Distribution Channel (USD MN)
• Hospital Pharmacies Market Sales by Geography (USD MN)
• Retail Pharmacies Market Sales by Geography (USD MN)
• Online Pharmacies Market Sales by Geography (USD MN)
• Global Market by Revenue
• North America Market by Revenue
• Europe Market by Revenue
• Asia Pacific Market by Revenue
• Latin America Market by Revenue
• Middle East & Africa Market by Revenue
• Recent Development in Industry
• Top Company Share Analysis

Kindly note that the above lis